Zemplar and respiratory tract infection Patient Reports February 10, 2012

Zemplar Side Effects Report #6126623-X
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 17, 2009. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL, MIMPARA, ISCOVER, MIACALCIN, LEPUR, FILICINE, AMLOPEN. Patient was hospitalized. Patient died on 03/17/2009.

Zemplar Side Effects Report #6130209-0
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 24, 2009. Female patient, 85 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute respiratory failure, communication disorder, cyanosis, dyspnoea, hypercalcaemia, hypercapnia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with RENAGEL, MIMPARA, ISCOVER, MIACALCIN, LEPUR, FILICINE, AMLOPEN. Patient was hospitalized. Patient died on 03/17/2009.

Zemplar Side Effects Report #4760157-X
Zemplar side effect was reported by a Consumer or non-health professional from SPAIN on Aug 25, 2005. Female patient, 82 years of age, was diagnosed with hyperparathyroidism secondary, renal failure chronic, prophylaxis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia , hyperphosphataemia, pyrexia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with ASPIRIN, ACARBOSE, AMLODIPINE BESYLATE, OMEPRAZOLE, IPRATROPIUM BROMIDE, SEVELAMER, CALCIUM POLYSTYRENE SULFONATE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #6057404-3
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 20, 2009. Female patient, 81 years of age, weighting 131.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: haemoptysis, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with NEORECORMON, VENOFER, SUPERAMIN, NEUROBION, MIMPARA, RENAGEL, OMEPRAZOLE, DIGOXIN. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5689405-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Mar 21, 2008. Male patient, 80 years of age, weighting 157.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, NEVROBION, FOLIC ACID, SEVELAMER, ISOSORBIDE MONONITRATE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5720322-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Apr 18, 2008. Male patient, 80 years of age, weighting 157.0 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine deficiency, vitamin b complex deficiency, hyperphosphataemia, coronary artery disease , chronic obstructive pulmonary disease and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with DARBEPOETIN ALFA, IRON DEXTRAN, LEVOCARNITINE, NEVROBION, FOLIC ACID, SEVELAMER, ISOSORBIDE MONONITRATE, THEOPHYLLINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5570694-6
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 12, 2007. Male patient, 76 years of age, weighting 160.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: dyspnoea, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with INTELECTA AMP, IRBESARTAN, DARBEPOETIN ALFA, SEVELAMER, TITRALAC, TAMSULOSIN, AMIODARONE HYDROCHLORIDE. Patient recovered.

Zemplar Side Effects Report #5890046-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 15, 2008. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: pyrexia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with CLOPIDOGREL, RABEPRAZOLE, FOLIC ACID, CARVEDILOL, FORSENOL, SEVELAMER, LEVOCARNITINE. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5905160-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 29, 2008. Male patient, 69 years of age, weighting 165.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: pyrexia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with CLOPIDOGREL, RABEPRAZOLE, FOLIC ACID, CARVEDILOL, FORSENOL, SEVELAMER, LEVOCARNITINE. Patient was hospitalized. Patient recovered.


Zemplar Side Effects Report #5620569-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 31, 2008. Female patient, 67 years of age, weighting 102.5 lb, was diagnosed with hyperparathyroidism secondary, prophylaxis, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: pyrexia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CINACALCET, SEVELAMER, FOLIC ACID, MEGACALCIUM. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5698385-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Apr 01, 2008. Female patient, 67 years of age, weighting 102.5 lb, was diagnosed with hyperparathyroidism secondary, prophylaxis, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chills, pyrexia, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CINACALCET, SEVELAMER, FOLIC ACID, MEGACALCIUM. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5385887-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on July 03, 2007. Male patient, 65 years of age, weighting 140.0 lb, was diagnosed with hyperparathyroidism secondary, anaemia, carnitine deficiency, muscle spasms, multi-vitamin deficiency, peripheral vascular disorder, gastritis, hypertension, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN BETA, LEVOCARNITINE, CERNEVIT, BUFLOMEDIL HYDROCHLORIDE, ESOMEPRAZOLE MAGNESIUM, SEVELAMER, CALCIUM CARBONATE. Patient was hospitalized. Patient died on 07/02/2007.

Zemplar Side Effects Report #6131703-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Mar 18, 2009. Female patient, 54 years of age, weighting 153.2 lb, was diagnosed with hyperparathyroidism secondary, anaemia, vitamin supplementation, hyperphosphataemia, hyperlipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with MIRCERA, VENOFER, NEUROBION, INTELECTA, INNOHEP, RENAGEL, LESCOL, PLAVIX. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5854700-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Aug 20, 2008. Male patient, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fluid retention, hyperkalaemia, pyrexia, respiratory tract infection, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FOLIC ACID, ACETYLSALICYLIC ACID SRT, PERSAMAR, ALUCAP CAPS, TICLOPIDINE HYDROCHLORIDE, CINACALCET. Patient was hospitalized. Patient died on 08/17/2008.


Zemplar Side Effects Report #5878324-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 09, 2008. Male patient, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fluid retention, hyperkalaemia, pyrexia, respiratory tract infection, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, FOLIC ACID, ACETYLSALICYLIC ACID SRT, PERSAMAR, ALUCAP CAPS, TICLOPIDINE HYDROCHLORIDE, CINACALCET. Patient was hospitalized. Patient died on 08/17/2008.

Zemplar Side Effects Report #6029008-X
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 29, 2008. Male patient, weighting 187.4 lb, was diagnosed with hyperparathyroidism secondary, anaemia, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: fluid retention, hyperkalaemia, pyrexia, respiratory tract infection, septic shock. Zemplar dosage: unknown. During the same period patient was treated with EPREX, FILICINE, SALOSPIR, PERSAMAR, ALUCAP CAPS, TICLID, MIMPARA. Patient was hospitalized. Patient died on 08/17/2008.

Zemplar Side Effects Report #4641619-2
Zemplar side effect was reported by a Consumer or non-health professional from on Mar 16, 2005. Female patient was diagnosed with hyperparathyroidism secondary, arthralgia, prophylaxis, nasopharyngitis, sleep disorder , polyneuropathy, renal osteodystrophy, depression  and was treated with Zemplar. After drug was administered, patient experienced the following side effects: enteritis infectious, gastroenteritis viral, gastrointestinal fungal infection, respiratory tract infection. Zemplar dosage: unknown. During the same period patient was treated with TRAMADOL, PARACETAMOL, RANITIDINE, DUOVENT, LORMETAZEPAM, GABAPEATINUM, SEVELAMER, TRAZODONE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.